Transplant Indications and Outcomes

Transplant Indications

The official journal of the American Society for Transplantation and Cellular Therapy (ASTCT), formerly the American Society for Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation (ASBMT), published the Hematopoietic Cell Transplant Standard Indications guideline in 2015.  This information is the authoritative guide frequently cited in insurance medical policies providing guidance providing a medical and scientific rationale for coverage of autologous and allogeneic stem cell transplantation.  

Below is a summary of common indications cited in the publication: 

• AML - Adult
• AML - Pediatric
• ALL - Adult
• ALL - Pediatric
• MDS
• CML
• CLL
• NHL
• Hodgkin Lymphoma
• Multiple Myeloma
• Severe Aplastic Anemia & Marrow Failure
• Sickle Cell Disease
• Immune Deficiency Diseases
• Inherited Metabolic Disorders
• Thalassemia
• Other Diseases

Download the publication to learn more about each indication’s corresponding allogeneic or autologous category.  (Link to publication in the Biology of Blood Marrow Transplant)